Institute for Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $938K | Sell |
7,422
-12
| -0.2% | -$1.58K | 0.08% | 212 |
|
|
2026
Q1 | $1.04M | Sell |
7,434
-42
| -0.6% | -$5.88K | 0.11% | 193 |
|
|
2025
Q4 | $918K | Buy |
7,476
+102
| +1% | +$12.4K | 0.1% | 208 |
|
|
2025
Q3 | $819K | Sell |
7,374
-25
| -0.3% | -$2.84K | 0.09% | 237 |
|
|
2025
Q2 | $820K | Buy |
7,399
+82
| +1% | +$8.73K | 0.09% | 229 |
|
|
2025
Q1 | $820K | Sell |
7,317
-40
| -0.5% | -$4.13K | 0.11% | 217 |
|
|
2024
Q4 | $680K | Sell |
7,357
-100
| -1% | -$9K | 0.09% | 237 |
|
|
2024
Q3 | $625K | Sell |
7,457
-94
| -1% | -$7.17K | 0.08% | 251 |
|
|
2024
Q2 | $518K | Buy |
7,551
+142
| +2% | +$9.48K | 0.07% | 271 |
|
|
2024
Q1 | $543K | Sell |
7,409
-24
| -0.3% | -$1.85K | 0.07% | 275 |
|
|
2023
Q4 | $602K | Hold |
7,433
| – | – | 0.1% | 234 |
|
|
2023
Q3 | $557K | Hold |
7,433
| – | – | 0.1% | 239 |
|
|
2023
Q2 | $573K | Sell |
7,433
-25
| -0.3% | -$1.99K | 0.1% | 233 |
|
|
2023
Q1 | $619K | Sell |
7,458
-111
| -1% | -$9.19K | 0.12% | 221 |
|
|
2022
Q4 | $650K | Sell |
7,569
-400
| -5% | -$31.7K | 0.14% | 206 |
|
|
2022
Q3 | $492K | Sell |
7,969
-7,024
| -47% | -$443K | 0.11% | 238 |
|
|
2022
Q2 | $927K | Sell |
14,993
-80
| -0.5% | -$4.95K | 0.18% | 145 |
|
|
2022
Q1 | $896K | Buy |
15,073
+7,050
| +88% | +$451K | 0.15% | 180 |
|
|
2021
Q4 | $583K | Buy |
8,023
+367
| +5% | +$25.3K | 0.1% | 255 |
|
|
2021
Q3 | $535K | Hold |
7,656
| – | – | 0.09% | 258 |
|
|
2021
Q2 | $527K | Sell |
7,656
-6
| -0.1% | -$401 | 0.09% | 265 |
|
|
2021
Q1 | $495K | Sell |
7,662
-278
| -4% | -$17.9K | 0.09% | 266 |
|
|
2020
Q4 | $463K | Sell |
7,940
-2,925
| -27% | -$176K | 0.09% | 267 |
|
|
2020
Q3 | $687K | Sell |
10,865
-230
| -2% | -$15.9K | 0.16% | 166 |
|
|
2020
Q2 | $854K | Sell |
11,095
-79
| -0.7% | -$6.05K | 0.21% | 129 |
|
|
2020
Q1 | $835K | Buy |
11,174
+70
| +0.6% | +$4.84K | 0.26% | 107 |
|
|
2019
Q4 | $722K | Buy |
11,104
+145
| +1% | +$9.44K | 0.16% | 183 |
|
|
2019
Q3 | $695K | Buy |
10,959
+652
| +6% | +$42.6K | 0.18% | 173 |
|
|
2019
Q2 | $696K | Sell |
10,307
-174
| -2% | -$11.4K | 0.15% | 204 |
|
|
2019
Q1 | $682K | Buy |
+10,481
| New | +$697K | 0.15% | 189 |
|
|
2018
Q4 | – | Sell |
-12,762
| Closed | -$975K | – | 294 |
|
|
2018
Q3 | $975K | Sell |
12,762
-3,370
| -21% | -$255K | 0.33% | 103 |
|
|
2018
Q2 | $1.15M | Buy |
16,132
+430
| +3% | +$30.4K | 0.37% | 92 |
|
|
2018
Q1 | $1.12M | Buy |
15,702
+3,266
| +26% | +$260K | 0.33% | 105 |
|
|
2017
Q4 | $899K | Sell |
12,436
-452
| -4% | -$34.3K | 0.21% | 148 |
|
|
2017
Q3 | $1.04M | Sell |
12,888
-674
| -5% | -$51.5K | 0.34% | 98 |
|
|
2017
Q2 | $968K | Buy |
+13,562
| New | +$902K | 0.27% | 123 |
|
Other funds holding GILD
Institute for Wealth Management's GILD Position: Q2 2026 in Review
Institute for Wealth Management reduced its Gilead Sciences (GILD) stake by 0.16% in Q2 2026, selling an estimated $1.58K and leaving 7,422 shares worth $938K. The position accounts for 0.08% of the portfolio, ranked #212.
Institute for Wealth Management first reported a position in GILD in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.15M in Q2 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Institute for Wealth Management held 7,422 shares of Gilead Sciences worth $938K as of Q2 2026.
- Institute for Wealth Management sold 12 Gilead Sciences shares in Q2 2026, an estimated $1.58K.
- Gilead Sciences made up 0.08% of Institute for Wealth Management's portfolio in Q2 2026, its #212 holding.
- Institute for Wealth Management first reported a position in Gilead Sciences in Q2 2017 and has held it in 36 quarters since.
- Institute for Wealth Management's Gilead Sciences position peaked at $1.15M in Q2 2018.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.